# Novartis

> <p><strong>Known for:</strong> The heart-failure drug Entresto, the psoriasis and arthritis treatment Cosentyx, and Kymriah, the first CAR-T therapy, which reprograms a patient's own immune cells to attack blood cancers.<br><strong>Employees:</strong> ~76,000</p>

![Novartis](https://euronomy.eu/media/luucnajb/novartis.png)

Novartis is a Swiss company headquartered in Basel, focused on oncology, cardiovascular, immunology and neuroscience, with major drugs including the heart-failure treatment Entresto, the autoimmune drug Cosentyx and the CAR-T cell therapy Kymriah.

Novartis sharpened its focus on innovative medicines by spinning off its generics division Sandoz in 2023, and it faces patent expirations across its portfolio.

https://www.novartis.com